Hepcidin expression and iron parameters change in Type 2 diabetic patients

被引:71
作者
Jiang, Fang [1 ]
Sun, Zhen-Zhen [1 ]
Tang, Yue-Ting [1 ]
Xu, Chuanqing [2 ]
Jiao, Xiao-Yang [1 ]
机构
[1] Shantou Univ Med Coll, Affiliated Hosp 1, Dept Hematol Lab, Shantou 515041, Guangdong, Peoples R China
[2] Hanshan Normal Univ, Chaozhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepcidin; Ferritin; IL-6; Type; 2; DM; INSULIN-RESISTANCE; CROSS-TALK; INFLAMMATION; FERRITIN; ASSOCIATION; TRANSFERRIN; FERROPORTIN; HOMEOSTASIS; ANEMIA; STORES;
D O I
10.1016/j.diabres.2011.03.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Iron may contribute to the pathogenesis of Type 2 diabetes mellitus (DM). The aim of this study was to determine iron regulator hepcidin and iron metabolic parameters in Type 2 DM patients, the relationships among them were evaluated in this specific sub-groups. Materials and methods: The study included sixty-four people: 34 cases of diabetes and 30 age-matched controls. Serum hepcidin, IL-6, hsCRP, ferritin, sTfR, EPO as well as other clinical parameters were detected, and the associations between hepcidin levels and iron/inflammatory parameters were analyzed in diabetes and the controls. Results: Serum ferritin and hepcidin levels in diabetic patients were significant higher than the controls (p < 0.001 respectively). A positive correlation between hepcidin and ferritin, as well as between ferritin and IL-6 levels was existed in diabetes and the control groups (p < 0.001 respectively). Conclusion: All of these data demonstrated that the higher hepcidin levels in diabetic patients may be due to those higher ferritin and IL-6 levels, the elevated hepcidin might have adaptive value through down-regulated iron absorb and play an important role in pathogenesis of Type 2 DM. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 31 条
[1]   Iron storage disease: Facts, fiction and progress [J].
Beutler, Emest .
BLOOD CELLS MOLECULES AND DISEASES, 2007, 39 (02) :140-147
[2]   Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients [J].
Chang, Julia ;
Bird, Robert ;
Clague, Alan ;
Carter, Andrew .
PATHOLOGY, 2007, 39 (03) :349-353
[3]   INSULIN INJECTION INCREASES THE LEVELS OF SERUM RECEPTORS FOR TRANSFERRIN AND INSULIN-LIKE GROWTH FACTOR-II MANNOSE-6-PHOSPHATE IN INTACT RATS [J].
CLAIRMONT, KB ;
CZECH, MP .
ENDOCRINOLOGY, 1990, 127 (04) :1568-1573
[4]   Oxidative stress, β-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis [J].
Cooksey, RC ;
Jouihan, HA ;
Ajioka, RS ;
Hazel, MW ;
Jones, DL ;
Kushner, JP ;
McClain, DA .
ENDOCRINOLOGY, 2004, 145 (11) :5305-5312
[5]   Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations [J].
Dallalio, G ;
Law, E ;
Means, RT .
BLOOD, 2006, 107 (07) :2702-2704
[6]   INSULIN RESISTANCE AND IRON OVERLOAD [J].
DANDONA, P ;
HUSSAIN, MAM ;
VARGHESE, Z ;
POLITIS, D ;
FLYNN, DM ;
HOFFBRAND, AV .
ANNALS OF CLINICAL BIOCHEMISTRY, 1983, 20 (MAR) :77-79
[7]   Inflammation: the link between insulin resistance, obesity and diabetes [J].
Dandona, P ;
Aljada, A ;
Bandyopadhyay, A .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :4-7
[8]   Effect of phlebotomy on plasma glucose and insulin concentrations [J].
Facchini, FS .
DIABETES CARE, 1998, 21 (12) :2190-2190
[9]   Cross-talk between iron metabolism and diabetes [J].
Fernández-Real, JM ;
López-Bermejo, A ;
Ricart, W .
DIABETES, 2002, 51 (08) :2348-2354
[10]   Insulin resistance, iron, and the liver [J].
Ferrannini, E .
LANCET, 2000, 355 (9222) :2181-2182